Medtronic plc. vs Merck & Company, Inc. — Stock Comparison
Q·Score Breakdown
7
Buy
Overall
7.3
Buy
Quality
Health
Growth
Valuation
Sentiment
MDT
Analysts see 34% upside to $108.00 consensus target.
MRK
High-quality business with 37% return on equity and 28% profit margins.
⚠ earnings contracting 19% year-over-year.
Analyst Consensus
BUY
Target $108.00 (+34.5%)
25 analysts
BUY
Target $129.74 (+17.7%)
27 analysts
Fundamentals
MDT
MRK
22.4×
Trailing P/E
15.1×
13.3×
Forward P/E
11.3×
13.0%
Profit Margin
28.1%
65.2%
Gross Margin
77.2%
9.4%
ROE
36.9%
8.7%
Revenue Growth
5.0%
-11.8%
Earnings Growth
-19.3%
0.76
Beta
0.28
—
Price / Book
—
$103.1B
Market Cap
$272.2B
$79 – $106
52-Week Range
$73 – $125
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.